Geron
GERN
#6216
Rank
โ‚น78.76 B
Marketcap
โ‚น123.38
Share price
-2.16%
Change (1 day)
-61.81%
Change (1 year)

EPS for Geron (GERN)

EPS in 2025 (TTM): -โ‚น10.38

According to Geron's latest financial reports the company's current EPS (TTM) is -โ‚น10.89. In 2024 the company made an earnings per share (EPS) of -โ‚น24.49 an increase over its 2023 EPS that were of -โ‚น29.94.

EPS history for Geron from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น10.38-57.64%
2024-โ‚น24.49-18.18%
2023-โ‚น29.94-8.33%
2022-โ‚น32.66-0%
2021-โ‚น32.6633.33%
2020-โ‚น24.49-25%
2019-โ‚น32.66140%
2018-โ‚น13.61-16.67%
2017-โ‚น16.33-0%
2016-โ‚น16.33-1.2970366926827E+18%
2015โ‚น0.0000000000-100%
2014-โ‚น21.77
2012-โ‚น48.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eterna Therapeutics
ERNA
-โ‚น6,959 63,825.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น591.50-5,533.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น45.36-516.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
โ‚น555.21-5,200.00%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-โ‚น52.62 383.33%๐Ÿ‡บ๐Ÿ‡ธ USA